Changzhen Sun
Skin Structure And Function Key Laboratory Of Luzhou
Luzhou, 646000, China
Luzhou, 646000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Correction: A NIR-Ⅱ-Immunostimulatory nanoplatform rewires immunometabolism to unleash STING-driven antitumor immunity.
Journal: Journal of nanobiotechnology
Published: August 22, 2026
Pluronic F127 engineered nanotheranostics for NIR-II fluorescence imaging and enhanced photodynamic therapy in melanoma.
Journal: Journal of materials chemistry. B
Published: July 30, 2026
Carrier-free self-assembled nanoparticles derived from traditional Chinese medicine active components: construction strategies and applications.
Journal: RSC advances
Published: May 18, 2026
A NIR-Ⅱ-Immunostimulatory nanoplatform rewires immunometabolism to unleash STING-driven antitumor immunity.
Journal: Journal of nanobiotechnology
Published: October 16, 2025
A dual-functional mitochondrial probe for melanoma visualization and PI3K/AKT/mTOR-EMT signaling axis-mediated antitumor therapy.
Journal: Colloids and surfaces. B, Biointerfaces
Published: March 10, 2025
A novel NIR-dependent IDO-inhibiting ethosomes treatment melanoma through PTT/PDT/immunotherapy synergy.
Journal: Colloids and surfaces. B, Biointerfaces
Published: December 26, 2024
Novel NIR fluorescent probe IR-546 inhibits melanoma through the AKT/GSK3β/β-catenin pathway.
Journal: Molecular medicine (Cambridge, Mass.)
Published: October 10, 2024
A novel NIR fluorescent probe inhibits melanoma progression through apoptosis and ERK/DRP1-mediated mitochondrial fission.
Journal: Bioorganic chemistry
Published: December 05, 2023
Multifunctional Near-Infrared Dye IR-817 Encapsulated in Albumin Nanoparticles for Enhanced Imaging and Photothermal Therapy in Melanoma.
Journal: International journal of nanomedicine
Published: June 08, 2023
A novel multifunctional mitochondrion-targeting NIR fluorophore probe inhibits tumour proliferation and metastasis through the PPARγ/ROS/β-catenin pathway.
Journal: European journal of medicinal chemistry
Published: March 18, 2023
A novel mitochondria-targeting compound exerts therapeutic effects against melanoma by inducing mitochondria-mediated apoptosis and autophagy in vitro and in vivo.
Journal: Environmental toxicology
Published: December 07, 2022
Mitochondrion-Targeted NIR Therapeutic Agent Suppresses Melanoma by Inducing Apoptosis and Cell Cycle Arrest via E2F/Cyclin/CDK Pathway.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 08, 2022
Last Updated: 09/26/2026